The Global Hba1c Testing Device Market was valued at USD 1,040.9 million in 2018, and is expected to reach USD 2,082.6 million by 2026, growing at a CAGR of 9.2% during the forecast period from 2019-2026. The key factors boosting growth of the market are the increasing number of patients suffering from chronic diseases, increase in need for quality patient care, efficiency in solutions. Furthermore, Efficiency, cost effectiveness, increasing awareness regarding glycated haemoglobin and being patient friendly are the factors which are major plus for the use of hba1c testing device in homecare settings, hospitals and diagnostic laboratories & clinics which are the end user segment.
In 2018, benchtop device held the largest share in global hba1c testing device market due to increasing rate of early diagnosis of the disease and most of the patients diagnosed prefer to have an accurate and less expensive result in short span of time. Majority of the patients diagnosed with type II diabetes can regulate the blood glucose levels by having the hba1c test which is done usually 3 times a year on an average and helps patients to know the level of glycated haemoglobin in the blood. Handheld device is expected to grow at the highest rate with its increasing usage in homecare setting.
Diagnostic laboratories and clinics end-use segment held the maximum share in global hba1c testing device market. Moreover, the homecare setting end-use segment is expected to grow significantly at a promising growth rate during the forecast period due to increasing usage of handheld device.
Based on geography, North America held the largest market share in 2018 because of high number of technological advanced hospitals, growth in number of hospitals and surgical centers in the region and exponential increase awareness in the population regarding technology and application. In addition, there has been a rise in the number of people wanting technological advanced device and software and services for the diagnosis and treatment. Asia Pacific is a growing region for Hba1c Testing Device market and is expected to grow at a moderate rate during the forecast period.
Key takeaways/key essentials:
- In 2018, the Benchtop device type held more than half of the market share.
- Bayer Healthcare AG, Roche Ltd and Abbott Laboratories are the leading players holding approximately around one third of the market share.
- The Homecare Setting end use segment is anticipated to grow at the highest rate during the forecast period from 2019 to 2026.
- Turbidimetric Inhibition Immunoassay technique is widely used in the Hba1c Testing Device field.
- North America region occupied maximum revenue share in global Hba1c Testing Device market in 2018.
Major prominent players operating in Global Hba1c Testing Device Market include Abbott Laboratories, Transasia Biomedicals Limited, Alere Incorporated , Arkray Incorporated , Danaher Co , Bio-Rad Laboratories , Siemens Healthcare , F.Hoffmann-La Roche, Trinity Biotech Plc and Bayer Healthcare among others.
This report includes analysis of the Global Hba1c Testing Device Market. The report is segmented into device type, technique, end user type and key geographies. The market comprises of Handheld and Benchtop Devices. The technique includes Ion Exchange Hplc, Enzymatic Assay, Affinity Binding Chromatography, Turbidimetric Inhibition Immunoassay and Others. The end user includes Hospital, Homecare Setting and Diagnostic Laboratories & Clinics.
The research report “Global Hba1c Testing Device Market” provides an in-depth analysis of the Hba1c Testing Device market. In this report, the market is segmented on the basis of device type, technique type, end-user and major geographies. The report highlights the key market drivers boosting the market growth as well as challenges faced by the market participants. The research report covers major data points such as market size and forecast for Hba1c Testing Device market. The report also includes the competitive landscape, major players and their strategies in 2018 along with major recent developments in impacted the market landscape.
For more details, Please Visit: https://www.gmiresearch.com/report/global-hba1c-testing-device-market-2019-2026/
Early buyers will get customization upto 25% on report
Contact Sarah Nash
U.S Office +1 860 881 2270
Europe Office +353 1 442 8820